Technical Data
K0005-15A
Kallikrein 12 (KLK12, DKFZp686H1078, Kallikrein-like Protein 5, KLKL5, Kallikrein Related Peptidase 12, MGC42603)
Description:
Kallikreins are a subgroup of serine proteases and are implicated in carcinogenesis. A novel KLK gene, KLK12, is expressed in a variety of tissues including salivary gland, stomach, uterus, lung, thymus, prostate, colon, brain, breast, thyroid, and trachea. It has applications as a novel cancer biomarker.

Applications:
Suitable for use in Western Blot. Other applications not tested.

Recommended Dilution:
Western Blot: 1:500-1:1000
Optimal dilutions to be determined by the researcher.

Storage and Stability:
May be stored at 4C for short-term only. For long-term storage and to avoid repeated freezing and thawing, aliquot and store at -20C. Aliquots are stable for at least 12 months at -20C. For maximum recovery of product, centrifuge the original vial after thawing and prior to removing the cap. Further dilutions can be made in assay buffer.
TypeIsotypeCloneGrade
PabIgGAffinity Purified
SizeStorageShippingSourceHost
100ug-20CBlue IceHumanRabbit
Concentration:
~1mg/ml
Immunogen:
Synthetic peptide corresponding to aa236-248 of human KLK12
Purity:
Purified by immunoaffinity chromatography.
Form
Supplied as a liquid in PBS, 0.02% sodium azide.
Specificity:
Reacts with residues 236-248 [KYVDWIRMIMRNN] of the human KLK12 protein.
Intended for research use only. Not for use in human, therapeutic, or diagnostic applications.
Yousef GM, Magklara A, and Diamandis EP. Genomics 2000 Nov
1;69(3):331-41